- Home
- AUPH vs EYE Comparison
AUPH vs EYE Comparison
Compare AUPH & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- EYE
- Stock Information
- Founded
- AUPH 1993
- EYE 1990
- Country
- AUPH Canada
- EYE United States
- Employees
- AUPH N/A
- EYE N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- EYE Ophthalmic Goods
- Sector
- AUPH Health Care
- EYE Health Care
- Exchange
- AUPH Nasdaq
- EYE Nasdaq
- Market Cap
- AUPH 1.1B
- EYE 900.5M
- IPO Year
- AUPH 1999
- EYE 2017
- Fundamental
- Price
- AUPH $8.19
- EYE $21.03
- Analyst Decision
- AUPH Strong Buy
- EYE Buy
- Analyst Count
- AUPH 2
- EYE 8
- Target Price
- AUPH $11.50
- EYE $17.75
- AVG Volume (30 Days)
- AUPH 1.4M
- EYE 2.8M
- Earning Date
- AUPH 07-31-2025
- EYE 05-07-2025
- Dividend Yield
- AUPH N/A
- EYE N/A
- EPS Growth
- AUPH N/A
- EYE N/A
- EPS
- AUPH 0.27
- EYE N/A
- Revenue
- AUPH $247,295,000.00
- EYE $1,850,850,000.00
- Revenue This Year
- AUPH $12.15
- EYE $7.11
- Revenue Next Year
- AUPH $18.31
- EYE $3.17
- P/E Ratio
- AUPH $30.78
- EYE N/A
- Revenue Growth
- AUPH 29.20
- EYE 4.31
- 52 Week Low
- AUPH $5.15
- EYE $9.56
- 52 Week High
- AUPH $10.67
- EYE $21.73
- Technical
- Relative Strength Index (RSI)
- AUPH 54.75
- EYE 78.25
- Support Level
- AUPH $7.91
- EYE $20.59
- Resistance Level
- AUPH $8.07
- EYE $21.73
- Average True Range (ATR)
- AUPH 0.24
- EYE 0.63
- MACD
- AUPH -0.00
- EYE -0.02
- Stochastic Oscillator
- AUPH 51.85
- EYE 79.77
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About EYE National Vision Holdings Inc.
National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.